Novo Nordisk
NVO
463 hedge funds and large institutions have $5.53B invested in Novo Nordisk in 2017 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 170 increasing their positions, 157 reducing their positions, and 61 closing their positions.
8% more repeat investments, than reductions
Existing positions increased: 170 | Existing positions reduced: 157
0.53% more ownership
Funds ownership: 15.48% → 16.02% (+0.53%)
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
1% less capital invested
Capital invested by funds: $5.6B → $5.53B (-$71.3M)
4% less funds holding
Funds holding: 482 → 463 (-19)
20% less first-time investments, than exits
New positions opened: 49 | Existing positions closed: 61
42% less call options, than puts
Call options by funds: $11.3M | Put options by funds: $19.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$194M |
| 2 |
Renaissance Technologies
New York
|
+$85.8M |
| 3 |
Millennium Management
New York
|
+$66.8M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$29.1M |
| 5 |
SGA
Sustainable Growth Advisers
Stamford,
Connecticut
|
+$20.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$79.1M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$65.1M |
| 3 |
Two Sigma Advisers
New York
|
-$26.3M |
| 4 |
DAC
Dividend Assets Capital
Ridgeland,
South Carolina
|
-$23.7M |
| 5 |
JP Morgan Chase
New York
|
-$22.8M |
NVO Hedge Fund Activity: Q1 2017 in Review
463 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q1 2017, worth a combined $5.53B — down 1.3% from $5.6B a quarter earlier.
Sellers outnumbered buyers: 61 funds closed out of NVO and 49 opened new positions — a net loss of 12 holders — while 157 trimmed existing stakes and 170 added.
The largest buyer was State Street, adding an estimated $194M. The largest seller was Capital International Investors, cutting an estimated $79.1M.
- 463 institutional investors held Novo Nordisk (NVO) as of Q1 2017, down from 482 in Q4 2016.
- Funds reported $5.53B of Novo Nordisk stock for Q1 2017, down 1.3% quarter-over-quarter.
- 49 funds opened new Novo Nordisk positions in Q1 2017 and 61 closed out, a net change of -12 holders.
- The largest Novo Nordisk buyer in Q1 2017 was State Street, an estimated $194M added.
- The largest Novo Nordisk seller in Q1 2017 was Capital International Investors, an estimated $79.1M sold.
Based on aggregated 13F filings for Q1 2017.